Spectrum Pharmaceuticals Inc (NASDAQ:SPPI)
| 8.33 Data as of May 24 |  -0.22 / -2.57%Today’s Change | 6.92 Today|||52-Week Range 17.48 | -25.53% Year-to-Date |
Latest SPPI News | Press Releases
| Biotech Stock Mailbag: Amarin, MannKind, Palatin May 24 / TheStreet.com | Spectrum Pharma Reports 1Q Loss - Analyst Blog May 14 / Zacks.com |
| The Gap Fill Play Starring Spectrum Pharma May 22 / StockTwits |
Today’s Trading
| Previous close | 8.55 |
| Today’s open | 8.52 |
| Day’s range | 8.29 - 8.58 |
| Volume | 581,949 |
| Average volume (3 months) | 1,453,268 |
| Market cap | $500.0M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +73.81% |
| Earnings growth (this year) | -114.50% |
| Earnings growth (next 5 years) | +22.00% |
| Revenue growth (last year) | +38.73% |
| P/E ratio | 11.7 |
| Price/Sales | 2.45 |
| Price/Book | 1.76 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MACKMerrimack Pharmaceut... | -0.06 | -1.14% |
| SGNTSagent Pharmaceutica... | -0.14 | -0.78% |
| ECYTEndocyte Inc | 0.00 | 0.00% |
| AVNRAvanir Pharmaceutica... | +0.01 | +0.29% |
Data as of 4:00pm ET, 05/24/2013
Financials
| Next reporting date | August 13, 2013 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $267.7M |
| Annual profit (last year) | $94.5M |
| Net profit margin | 35.32% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Rajesh C. Shrotriya, MD |
Chief Operating Officer & Executive Vice President Kenneth Joseph Keller, MBA |
Corporate headquarters Henderson, Nevada |
Forecasts
